Regulated phosphosignaling associated with breast cancer subtypes and druggability

Authors

Kuan-lin Huang, Mount Sinai School of Medicine
Yige Wu, Washington University School of Medicine in St. Louis
Tina Primeau, Washington University School of Medicine in St. Louis
Joshua F. McMichael, Washington University School of Medicine in St. Louis
Adam D. Scott, Washington University School of Medicine in St. Louis
Song Cao, Washington University School of Medicine in St. Louis
Michael C. Wendl, Washington University School of Medicine in St. Louis
Kimberly J. Johnson, Washington University School of Medicine in St. Louis
Jason Held, Washington University School of Medicine in St. Louis
Sherri Davies, Washington University School of Medicine in St. Louis
R. Reid Townsend, Washington University School of Medicine in St. Louis
Feng Chen, Washington University School of Medicine in St. Louis
David Fenyö, Washington University in St. Louis
Shunqiang Li, Washington University School of Medicine in St. Louis
Tao Liu, Washington University School of Medicine in St. Louis
Li Ding, Washington University School of Medicine in St. Louis
et al.

Journal

Molecular and Cellular Proteomics

Publication Date

2019

Volume

18

Issue

8

First Page

1630

Last Page

1650

Document Type

Open Access Publication

DOI

10.1074/mcp.RA119.001243

Rights and Permissions

This research was originally published in Molecular and Cellular Proteomics. Huang, K. -., Wu, Y., Primeau, T., Wang, Y. -., Gao, Y., McMichael, J. F., . . . Ding, L. (2019). Regulated phosphosignaling associated with breast cancer subtypes and druggability. Molecular and Cellular Proteomics, 18(8), 1630-1650. doi:10.1074/mcp.RA119.001243 © the American Society for Biochemistry and Molecular Biology.

Recommended Citation

Huang, Kuan-lin; Wu, Yige; Primeau, Tina; McMichael, Joshua F.; Scott, Adam D.; Cao, Song; Wendl, Michael C.; Johnson, Kimberly J.; Held, Jason; Davies, Sherri; Townsend, R. Reid; Chen, Feng; Fenyö, David; Li, Shunqiang; Liu, Tao; Ding, Li; and et al., "Regulated phosphosignaling associated with breast cancer subtypes and druggability." Molecular and Cellular Proteomics. 18, 8. 1630 - 1650. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8503